AUTL
Autolus Therapeutics plc
1.90$
-4.6%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 50.7% | 90.5% | 95.8% | 91.5% | 91.5% | 82.1% | 65.9% | 85.5% | 86.8% | 73.3% | 84.4% | 74.0% | |
| 45.0% | 82.1% | 92.2% | 87.0% | 87.0% | 69.7% | 52.4% | 76.5% | 78.0% | 63.8% | 29.0% | 17.7% | |
| 45.0% | 82.1% | 92.2% | 87.0% | 87.0% | 69.7% | 52.4% | 76.5% | 78.0% | 63.8% | 75.1% | 51.0% | |
| 3.3% | 6.4% | 3.2% | 3.1% | 4.3% | 10.1% | 10.1% | 0.0% | 5.9% | 0.3% | 6.2% | 12.9% | |
| – | – | – | 1.0% | 1.0% | 2.6% | -10.1% | 2.5% | 2.9% | -6.3% | 0.5% | 5.6% | |
| 2.7% | 9.5% | 4.2% | 6.2% | 9.2% | 17.0% | 30.5% | 12.9% | 11.9% | – | – | – | |
| 45.2% | 27.8% | 4.9% | 4.3% | 4.3% | 0.1% | 0.1% | 0.0% | – | – | 1.6% | 3.4% | |
| 8.6% | 10.2% | 4.1% | 5.8% | 5.8% | 16.0% | 28.6% | 22.7% | 39.1% | 70.3% | 45.4% | 69.8% | |
| 8.6% | 8.0% | 3.4% | 5.8% | 5.8% | 8.2% | 11.4% | 7.0% | 9.5% | 11.9% | 7.8% | 12.5% | |
| – | – | – | – | – | 0.8% | 1.2% | 1.1% | 1.0% | 1.3% | 0.4% | 2.5% | |
| 7.5% | 4.2% | 1.3% | 5.8% | 1.4% | 0.4% | 0.8% | 0.1% | 0.1% | 0.0% | 0.3% | 0.5% | |
| 91.4% | 89.8% | 95.9% | 94.2% | 94.2% | 84.0% | 71.4% | 77.3% | 60.9% | 29.7% | 54.6% | 30.2% | |
| -41.2% | -82.4% | -32.2% | 75.3% | 75.3% | -78.1% | -128.9% | -128.5% | -136.7% | -234.0% | -140.4% | -235.4% | |
| 60.8% | 40.3% | 9.3% | 14.5% | 14.5% | 14.2% | 17.5% | 17.8% | 19.4% | 46.3% | 32.6% | 45.2% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.